Abstract
Cancer is the second leading cause of death worldwide, with early detection and appropriate therapy being the best alternatives to reduce the risk of mortality. Despite the recent advances in investigating biomarkers for early cancer detection, diagnosis strategies still lack improvements in the selectivity for the capture of circulating tumor cells (CTCs) and the detection method's sensi…